- study and processing of transition metals (the “fuel” to feed the cells LENR);
- study and analysis of multiple cells compared simultaneously (powered by different types of “fuel” and driven by different procedures).
- Nichenergy Srl (composed exclusively by prof. Piantelli and the first financing partners that have allowed the resumption of work) that owns the technology, patents, laboratory, and has signed an agreement with a corporation that contributes significantly to the development of research and split with 50% Srl Nichenergy any revenues that will accrue.
- Protium Srl of which may become part (through the purchase of shares) all those (individuals, businesses, companies) who want to contribute to the project by investing capital or other resources and will receive 20% of all revenues that Nichenergy Srl will derive the territory of the European Community.
Piantelli has been granted a patent by the European Patent Office for a nickel-hydrogen reaction process and it looks like he is setting up to try and compete with the efforts of Andrea Rossi, who has rather taken all the attention in the area of nickel-hydrogen LENR. The work of Piantelli has been done, as mentioned above, without much fanfare or publicity, and I’m not aware of any public demonstrations or validations of his systems, and it would be very interesting to get more details of the testing that has been carried out.
Although the late Sergio Focardi, Andrea Rossi’s partner and collaborator worked first on nickel-hydrogen LENR with Piantelli, Rossi has been somewhat dismissive of Piantelli’s work, at one time mentioning that the process described in the patent did not work. I expect that at some point we’ll see legal challenges launched in this arena.